drugset / Trial / NCT00000102

Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets

NCT00000102

Parallel-groupDouble-blindTreatment

Summary

This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nifedipine Other / unclassified